Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021.

IF 3.4 4区 医学 Q2 RHEUMATOLOGY
Wenhao Zhang, Dongmei Zhuang, Huan Lu, Ziyan Lv, Limin Huang, He Du, Jin Chang, Mengmeng Xiao, Mingyu Chen, Wenjie Ying, Haoyang Lei, Xiaoming Li
{"title":"Predictions of rheumatoid arthritis burden in 204 countries and territories by 2044: based on the Global Burden of Disease Study 2021.","authors":"Wenhao Zhang, Dongmei Zhuang, Huan Lu, Ziyan Lv, Limin Huang, He Du, Jin Chang, Mengmeng Xiao, Mingyu Chen, Wenjie Ying, Haoyang Lei, Xiaoming Li","doi":"10.55563/clinexprheumatol/7dijpb","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We conducted a comprehensive analysis of the spatiotemporal dynamics of rheumatoid arthritis (RA), including age‑standardised prevalence (ASPR), incidence (ASIR), and disability‑adjusted life years (DALYs, ASDR), from 1990 to 2021, and projected trends through 2044 using data from the Global Burden of Disease (GBD) 2021 to inform and strengthen global prevention, control strategies, and public health policy for RA.</p><p><strong>Methods: </strong>ASPR, ASIR, and ASDR estimates for 204 countries and territories (1990-2021) were retrieved from GBD 2021. We quantified temporal trends by the estimated annual percentage change (EAPC) and average annual percentage change (AAPC). We examined gender‑age‑specific differences in ASPR, ASIR, and ASDR and the relationships between RA‑related DALYs and risk factors across strata. What's more, we employed AutoRegressive Integrated Moving Average (ARIMA) and the Nordpred age‑period‑cohort model to forecast prevalence and incidence through 2044. All statistical analyses were performed in R 4.4.1 and Joinpoint Trend Analysis Software.</p><p><strong>Results: </strong>Between 1990 and 2021, global ASPR and ASIR rose (AAPC: 0.44 and 0.40, respectively), while ASDR declined modestly (AAPC: -0.03). In 2021, Ireland exhibited the highest ASPR (529.08) and ASIR (35.08), whereas Mexico recorded the highest ASDR (87.45). Although higher sociodemographic index (SDI) regions bore a greater RA burden overall, lower SDI regions experienced more rapid increases. Across all metrics, women - particularly those aged ≥60 years - demonstrated higher rates than men. 'Smoking' emerged as a vital risk of DALYs across age groups, genders, and regions. Projections from Nordpred and ARIMA model indicate continued rapid growth in prevalence and incidence cases through 2044, with more gradual increases in ASPR and ASIR.</p><p><strong>Conclusions: </strong>Global prevalence and incidence of RA are projected to rise further. Detailed knowledge of these trends and their drivers is essential to inform targeted interventions and mitigate the worldwide impact of RA.</p>","PeriodicalId":10274,"journal":{"name":"Clinical and experimental rheumatology","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and experimental rheumatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.55563/clinexprheumatol/7dijpb","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: We conducted a comprehensive analysis of the spatiotemporal dynamics of rheumatoid arthritis (RA), including age‑standardised prevalence (ASPR), incidence (ASIR), and disability‑adjusted life years (DALYs, ASDR), from 1990 to 2021, and projected trends through 2044 using data from the Global Burden of Disease (GBD) 2021 to inform and strengthen global prevention, control strategies, and public health policy for RA.

Methods: ASPR, ASIR, and ASDR estimates for 204 countries and territories (1990-2021) were retrieved from GBD 2021. We quantified temporal trends by the estimated annual percentage change (EAPC) and average annual percentage change (AAPC). We examined gender‑age‑specific differences in ASPR, ASIR, and ASDR and the relationships between RA‑related DALYs and risk factors across strata. What's more, we employed AutoRegressive Integrated Moving Average (ARIMA) and the Nordpred age‑period‑cohort model to forecast prevalence and incidence through 2044. All statistical analyses were performed in R 4.4.1 and Joinpoint Trend Analysis Software.

Results: Between 1990 and 2021, global ASPR and ASIR rose (AAPC: 0.44 and 0.40, respectively), while ASDR declined modestly (AAPC: -0.03). In 2021, Ireland exhibited the highest ASPR (529.08) and ASIR (35.08), whereas Mexico recorded the highest ASDR (87.45). Although higher sociodemographic index (SDI) regions bore a greater RA burden overall, lower SDI regions experienced more rapid increases. Across all metrics, women - particularly those aged ≥60 years - demonstrated higher rates than men. 'Smoking' emerged as a vital risk of DALYs across age groups, genders, and regions. Projections from Nordpred and ARIMA model indicate continued rapid growth in prevalence and incidence cases through 2044, with more gradual increases in ASPR and ASIR.

Conclusions: Global prevalence and incidence of RA are projected to rise further. Detailed knowledge of these trends and their drivers is essential to inform targeted interventions and mitigate the worldwide impact of RA.

到2044年对204个国家和地区类风湿关节炎负担的预测:基于2021年全球疾病负担研究
目的:我们对1990年至2021年类风湿关节炎(RA)的时空动态进行了全面分析,包括年龄标准化患病率(ASPR)、发病率(ASIR)和残疾调整生命年(DALYs, ASDR),并利用2021年全球疾病负担(GBD)的数据预测到2044年的趋势,以通知和加强全球预防、控制策略和RA的公共卫生政策。方法:从GBD 2021中检索204个国家和地区(1990-2021)的ASPR、ASIR和ASDR估计值。我们通过估算年百分比变化(EAPC)和平均年百分比变化(AAPC)量化了时间趋势。我们检查了ASPR、ASIR和ASDR的性别年龄特异性差异,以及RA相关DALYs与各阶层风险因素之间的关系。此外,我们采用自回归综合移动平均(ARIMA)和Nordpred年龄-时期-队列模型来预测到2044年的患病率和发病率。所有统计分析均在r4.4.1和Joinpoint趋势分析软件中进行。结果:1990年至2021年间,全球ASPR和ASIR上升(AAPC分别为0.44和0.40),而ASDR略有下降(AAPC为-0.03)。2021年,爱尔兰的ASPR(529.08)和ASIR(35.08)最高,而墨西哥的ASDR(87.45)最高。虽然高社会人口指数(SDI)地区总体上承担了更大的RA负担,但低SDI地区的RA负担增加更快。在所有指标中,女性——尤其是年龄≥60岁的女性——的发病率高于男性。“吸烟”成为各年龄组、性别和地区DALYs的重要风险因素。Nordpred和ARIMA模型的预测表明,到2044年,患病率和发病率将继续快速增长,ASPR和ASIR的增长将更加缓慢。结论:全球RA患病率和发病率预计将进一步上升。详细了解这些趋势及其驱动因素对于有针对性的干预措施和减轻风湿性关节炎的全球影响至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.10
自引率
18.90%
发文量
377
审稿时长
3-6 weeks
期刊介绍: Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信